Back to results
US 5,340,822 AGranted
Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present
AssigneeElf Sanofi
InventorsXavier Emonds-Alt, Patrick Gueule, Vincenzo Proietto, Pierre Goulaouic, deceased, by Marie Bousquet, heir, by Catherine M. L. Goulaouic, heir
Life of this patent
Estimating the term…
Abstract
The invention relates to polycyclic amine compounds of formula (I) ##STR1## where Y. m. Ar', n, p, Q, T, q and Z are defined herein. The invention also relates to methods of making the compounds of formula (I) and pharmaceutical compositions which contain the compounds of formula (I). The inventive compounds are useful as neurokinin receptor antagonists, and are useful for the treatment of any substance P-dependent and neurokinin-dependent pathological condition.
Claims9
A compound of the formula ##STR113## in which:
- Y is
- either a group Cy--N or Cy--CH.sub.2 --N, in which:
- Cy is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a C.sub.1 -C.sub.4 alkyl and a trifluoromethyl, said substituents being identical or different;
- a C.sub.3 -C.sub.7 cycloalkyl group;
- a pyrimidyl group or a pyridyl group;
- or a group ##STR114## in which:
- Ar is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a trifluoromethyl and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a pyridyl group or a thienyl group;
- x is zero or one;
- and
- X is a hydrogen;
- a hydroxyl;
- a C.sub.1 -C.sub.4 alkoxy;
- a C.sub.1 -C.sub.4 acyloxy;
- a carboxyl;
- a C.sub.1 -C.sub.4 carbalkoxy;
- a cyano;
- a group --N(X.sub.1).sub.2, in which the groups X.sub.1 independently are hydrogen, a C.sub.1 -C.sub.4 alkyl, a C.sub.1 -C.sub.4 hydroxyalkyl or a C.sub.1 -C.sub.4 acyl, or else --(X.sub.1).sub.2 forms, with the nitrogen atom to which it is bonded, a heterocycle selected from the group consisting of pyrrolidine, piperidine and morpholine;
- or a group --S--X.sub.2, in which X.sub.2 is hydrogen or a C.sub.1 -C.sub.4 alkyl group;
- or else X forms a double bond with the carbon atom to which it is bonded and with the adjacent carbon atom in the heterocycle;
- m is 2 or 3;
- Ar' is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a thienyl;
- a benzothienyl;
- a naphthyl or an indolyl;
- n is 0, 1, 2 or 3;
- p is 1 or 2, and when p is equal to 2, n is then equal to 1 and Q is two hydrogen atoms;
- Q is oxygen or two hydrogen atoms;
- T is a group selected from ##STR115## q is 0, 1, 2 or 3;
- and Z is phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- a naphthyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl and a hydroxyl;
- a pyridyl;
- a thienyl;
- an indolyl;
- a quinolyl;
- a benzothienyl;
- an imidazolyl;
- said pyridyl, thienyl, indolyl, quinolyl, benzothienyl or imidazolyl groups being unsubstituted or monosubstituted or polysubstituted by a C.sub.1 -C.sub.4 alkyl or hydroxyl;
- or else when T is --C.dbd.O, --(CH.sub.2).sub.q --Z represents a group where q=0, and Z is a benzyl group substituted on the ##STR116## the benzyl group by a substituent selected from the group consisting of a hydroxyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, and the benzyl group is unsubstituted or substituted on the aromatic ring by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- or a salt thereof with a mineral or organic acid, or, when ##STR117## a quaternary ammonium salt thereof, formed with nitrogen (b) of the piperidine, or an N-oxide derivative formed with this same nitrogen atom.
37 more elements
An optically pure compound of the formula ##STR118## in which:
- "*" means that the carbon atom marked with this symbol has a determined (+) or (-) absolute configuration, and
- Y is
- either a group Cy--N or Cy--CH.sub.2 --N, in which:
- Cy is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a C.sub.1 -C.sub.4 alkyl and a trifluoromethyl, said substituents being identical or different;
- a C.sub.3 -C.sub.7 cycloalkyl group;
- a pyrimidyl group or a pyridyl group;
- or a group ##STR119## in which:
- Ar is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a trifluoromethyl and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a pyridyl group or a thienyl group;
- x is zero or one;
- and
- X is a hydrogen;
- a hydroxyl;
- a C.sub.1 -C.sub.4 alkoxy;
- a C.sub.1 -C.sub.4 acyloxy;
- a carboxyl;
- a C.sub.1 -C.sub.4 carbalkoxy;
- a cyano;
- a group --N(X.sub.1).sub.2, in which the groups X.sub.1 independently are hydrogen, a C.sub.1 -C.sub.4 alkyl, a C.sub.1 -C.sub.4 hydroxyalkyl or a C.sub.1 -C.sub.4 acyl, or else --(X.sub.1).sub.2 forms, with the nitrogen atom to which it is bonded, a heterocycle selected from the group consisting of pyrrolidine, piperidine and morpholine;
- or a group --S--X.sub.2, in which X.sub.2 is hydrogen or a C.sub.1 -C.sub.4 alkyl group;
- or else X forms a double bond with the carbon atom to which it is bonded and with the adjacent carbon atom in the heterocycle;
- m is 2 or 3;
- Ar' is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a thienyl;
- a benzothienyl;
- a naphthyl or an indolyl;
- n is 0, 1, 2 or 3;
- p is 1 or 2, and when p is equal to 2, n is then equal to 1 and Q is two hydrogen atoms;
- Q is oxygen or two hydrogen atoms;
- T is a group selected from ##STR120## q is 0, 1, 2 or 3;
- and Z is phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- a naphthyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl and a hydroxyl;
- a pyridyl;
- a thienyl;
- an indolyl;
- a quinolyl;
- a benzothienyl;
- an imidazolyl;
- said pyridyl thienyl, indolyl, quinolyl, benzothienyl or imidazolyl groups being unsubstituted or monosubstituted or polysubstituted by a C.sub.1 -C.sub.4 alkyl or hydroxyl;
- or else when T is --C.dbd.O, --(CH.sub.2).sub.q --Z represents a group where q=0, and Z is a benzyl group substituted on the ##STR121## group of the benzyl group by a substituent selected from the group consisting of a hydroxyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, and the benzyl group is unsubstituted or substituted on the aromatic ring by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- or a salt thereof with a mineral or organic acid, or, with nitrogen atom (b), a quaternary ammonium salt thereof, or an N-oxide derivative.
38 more elements
A pharmaceutical composition comprising at least one pharmaceutical excipient and a compound of formula (I) according to claim ##STR128## in which:
- Y is
- either a group Cy--N or Cy--Ch.sub.2 --N, in which:
- Cy is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a C.sub.1 -C.sub.4 alkyl and a trifluoromethyl, said substituents being identical or different;
- a C.sub.3 -C.sub.7 cycloalkyl group;
- a pyrimidyl group or a pyridyl group;
- or a group ##STR129## in which:
- Ar is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a hydroxyl, a C.sub.1 -C.sub.4 alkoxy, a trifluoromethyl and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a pyridyl group or a thienyl group;
- x is zero or one;
- and
- X is a hydrogen;
- a hydroxyl;
- a C.sub.1 -C.sub.4 alkoxy;
- a C.sub.1 -C.sub.4 acyloxy;
- a carboxyl;
- a C.sub.1 -C.sub.4 carbalkoxy;
- a cyano;
- a group --N(X.sub.1).sub.2, in which the groups X.sub.1 independently are hydrogen, a C.sub.1 -C.sub.4 alkyl, a C.sub.1 -C.sub.4 hydroxyalkyl or a C.sub.1 -C.sub.4 acyl, or else --(X.sub.1).sub.2 forms, with the nitrogen atom to which it is bonded, a heterocycle selected from the group consisting of pyrrolidine, piperidine and morpholine;
- or a group --S--X.sub.2, in which X.sub.2 is hydrogen or a C.sub.1 -C.sub.4 alkyl group;
- or else X forms a double bond with the carbon atom to which it is bonded and with the adjacent carbon atom in the heterocycle;
- m is 2 or 3;
- Ar' is a phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of hydrogen, a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, said substituents being identical or different;
- a thienyl;
- a benzothienyl;
- a naphthyl or an indolyl;
- n is 0, 1, 2 or 3;
- p is 1 or 2, and when p is equal to 2, n is then equal to 1 and Q is two hydrogen atoms;
- Q is oxygen or two hydrogen atoms;
- T is a group selected from ##STR130## q is 0, 1, 2 or 3;
- and Z is phenyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen atom, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- a naphthyl which is unsubstituted or monosubstituted or polysubstituted by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl and a hydroxyl;
- a pyridyl;
- a thienyl;
- an indolyl;
- a quinolyl;
- a benzothienyl an imidazolyl;
- said pyridyl, thienyl, indolyl, quinolyl, benzothienyl or imidazolyl groups being unsubstituted, or monosubstituted or polysubstituted by a C.sub.1 -C.sub.4 alkyl or hydroxyl;
- or else when T is --C.dbd.O, --(CH.sub.2).sub.q --Z represents a group where q=0, and Z is a benzyl group substituted on the ##STR131## group of the benzyl group by a substituent selected from the group consisting of a hydroxyl, a C.sub.1 -C.sub.4 alkoxy and a C.sub.1 -C.sub.4 alkyl, and the benzyl group is unsubstituted or substituted on the aromatic ring by a substituent selected from the group consisting of a halogen, a trifluoromethyl, a C.sub.1 -C.sub.4 alkyl, a hydroxyl and a C.sub.1 -C.sub.4 alkoxy;
- or a salt thereof with a mineral or organic acid, or, when ##STR132## a quaternary ammonium salt thereof formed with nitrogen (b) of the piperidine, or an N-oxide derivative formed with this same nitrogen atom or a pharmaceutically acceptable salt thereof.
36 more elements
Dependencies are inferred from the claim text.